Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 1
2007 2
2008 1
2009 1
2010 2
2011 4
2012 9
2013 11
2014 14
2015 14
2016 12
2017 8
2018 3
2019 9
2020 5
2021 15
2022 11
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Results by year

Filters applied: . Clear all
Page 1
Mechanobiology of cancerogenesis.
Raudenská M, Navrátil J, Gumulec J, Masařík M. Raudenská M, et al. Among authors: masarik m. Klin Onkol. 2021 Spring;34(3):202-210. doi: 10.48095/ccko2021202. Klin Onkol. 2021. PMID: 34362256 English.
Metabolic tricks of cancer cells.
Hönigova K, Navratil J, Peltanova B, Polanska HH, Raudenska M, Masarik M. Hönigova K, et al. Among authors: masarik m. Biochim Biophys Acta Rev Cancer. 2022 May;1877(3):188705. doi: 10.1016/j.bbcan.2022.188705. Epub 2022 Mar 8. Biochim Biophys Acta Rev Cancer. 2022. PMID: 35276232 Review.
Caveolin-1 in oncogenic metabolic symbiosis.
Raudenska M, Gumulec J, Balvan J, Masarik M. Raudenska M, et al. Among authors: masarik m. Int J Cancer. 2020 Oct 1;147(7):1793-1807. doi: 10.1002/ijc.32987. Epub 2020 Apr 21. Int J Cancer. 2020. PMID: 32196654 Free article. Review.
Unexpected therapeutic effects of cisplatin.
Raudenska M, Balvan J, Fojtu M, Gumulec J, Masarik M. Raudenska M, et al. Among authors: masarik m. Metallomics. 2019 Jul 17;11(7):1182-1199. doi: 10.1039/c9mt00049f. Metallomics. 2019. PMID: 31098602 Review.
TET protein inhibitors: Potential and limitations.
Kaplánek R, Kejík Z, Hajduch J, Veselá K, Kučnirová K, Skaličková M, Venhauerová A, Hosnedlová B, Hromádka R, Dytrych P, Novotný P, Abramenko N, Antonyová V, Hoskovec D, Babula P, Masařík M, Martásek P, Jakubek M. Kaplánek R, et al. Among authors: masarik m. Biomed Pharmacother. 2023 Oct;166:115324. doi: 10.1016/j.biopha.2023.115324. Epub 2023 Aug 18. Biomed Pharmacother. 2023. PMID: 37598475 Free article. Review.
Novel Mitochondria-targeted Drugs for Cancer Therapy.
Fialova JL, Raudenska M, Jakubek M, Kejik Z, Martasek P, Babula P, Matkowski A, Filipensky P, Masarik M. Fialova JL, et al. Among authors: masarik m. Mini Rev Med Chem. 2021;21(7):816-832. doi: 10.2174/1389557520666201118153242. Mini Rev Med Chem. 2021. PMID: 33213355 Review.
Iron Complexes of Flavonoids-Antioxidant Capacity and Beyond.
Kejík Z, Kaplánek R, Masařík M, Babula P, Matkowski A, Filipenský P, Veselá K, Gburek J, Sýkora D, Martásek P, Jakubek M. Kejík Z, et al. Among authors: masarik m. Int J Mol Sci. 2021 Jan 11;22(2):646. doi: 10.3390/ijms22020646. Int J Mol Sci. 2021. PMID: 33440733 Free PMC article. Review.
Metallothionein polymorphisms in pathological processes.
Raudenska M, Gumulec J, Podlaha O, Sztalmachova M, Babula P, Eckschlager T, Adam V, Kizek R, Masarik M. Raudenska M, et al. Among authors: masarik m. Metallomics. 2014 Jan;6(1):55-68. doi: 10.1039/c3mt00132f. Metallomics. 2014. PMID: 24068159 Review.
121 results